Von Willebrand Tests During Heavy Bleeding: Ask About Follow-Up
PeriodsArticleAcute bleeding and anemia can affect clotting-protein levels. A normal-looking report needs to be read alongside the test names, timing and bleeding history.
In this article
Why the day of the blood draw matters
Von Willebrand factor, or VWF, helps blood clot. Its level can rise during a bleeding episode, injury or pregnancy. The 2021 international diagnostic guideline therefore recommends testing when a person is at their baseline state of health. A result taken during an acute episode may need a later review.1
That does not mean every normal result is misleading or that testing during bleeding is useless. Bring the report and the circumstances of the blood draw to the clinician interpreting it.
What the emergency-department study found
A 2021 Atlanta study identified 221 adolescents receiving emergency or inpatient care for acute heavy menstrual bleeding. Of 127 tested initially, 39 had paired tests during the episode and after bleeding resolved. Median VWF antigen was 129% initially and 83% at follow-up, in the laboratory’s percentage units. Factor VIII and VWF activity were also higher during acute bleeding.2
This was a retrospective study with limited follow-up, involving many patients with substantial anemia. Its results cannot supply a personal false-negative probability or be transferred unchanged to women in their forties and fifties. Initial testing still identified most affected patients in the cohort.2
Check which tests were actually done
The international guideline identifies VWF antigen, platelet-dependent VWF activity and factor VIII activity as specific tests for this assessment. Antigen concerns how much VWF is present; activity concerns how it functions. A message saying “your blood tests are normal” is not enough detail to establish which investigations were included.1
Ask for a copy showing the names, values, units and laboratory reference ranges. Add the date, whether bleeding was active and whether anemia or another illness was present. Let the clinician determine whether the results reflect baseline health and whether the bleeding history warrants further testing.
Should I stop the pill before a repeat test?
A 2024 ASH Education Program3 review says combined pills containing 30 micrograms of estrogen or less do not need to be stopped solely for diagnostic testing. It distinguishes these doses from higher-dose estrogen exposure, which can affect VWF levels. This is a reason to review the exact prescription, rather than stopping contraception yourself.3
The review emphasizes repeat testing when initial results may not reflect baseline, especially with borderline findings. Ask the team to decide the timing after acute bleeding or significant anemia, and to specify what to do with existing treatment. There is no single waiting interval to copy from this article.3
Leave with a follow-up arrangement
Period, Handled discusses bleeding-disorder assessment and heavy periods since the first menstrual cycle. Bring that history alongside nosebleeds, bruising and bleeding after dental work or surgery. Our bleeding-disorder overview explains those clues.
Ask: “Were these tests taken during a period of acute bleeding or anemia? Do we need to repeat any, who will arrange them, and who will review the results?”
ACOG4 advises emergency care for hourly pad or tampon changes lasting more than two hours accompanied by symptoms such as chest pain, shortness of breath, lightheadedness or dizziness. A planned repeat test must not postpone urgent care.4
Educational information. A hematology or gynecology team should interpret bleeding-disorder tests and decide whether repeat testing is needed. Do not delay treatment of active heavy bleeding while arranging a diagnostic follow-up.
Girl Playbook sells this book. It provides education and worksheets, not individualized medical care.
Sources
The research behind this article, in the order it’s cited. How we source our articles.
- ASH / ISTH / NHF / WFH, 2021 guideline2021 guidelines on diagnosis of von Willebrand disease: executive summary (opens in a new tab)ab
- Research and Practice in Thrombosis and Haemostasis, 2021Elevated von Willebrand factor levels during heavy menstrual bleeding episodes limit the diagnostic utility for von Willebrand disease (opens in a new tab)ab
- ASH Education Program, 2024von Willebrand disease and heavy menstrual bleeding: when and how to test (opens in a new tab)abc
- ACOG, Accessed 2026Abnormal Uterine Bleeding (opens in a new tab)ab
Spotted something out of date? Tell us and we’ll check it.
